DK1684770T3 - Oligo-beta-(1, 3) -glucan og monoklonale antistoffer mod kræft - Google Patents
Oligo-beta-(1, 3) -glucan og monoklonale antistoffer mod kræftInfo
- Publication number
- DK1684770T3 DK1684770T3 DK04791108T DK04791108T DK1684770T3 DK 1684770 T3 DK1684770 T3 DK 1684770T3 DK 04791108 T DK04791108 T DK 04791108T DK 04791108 T DK04791108 T DK 04791108T DK 1684770 T3 DK1684770 T3 DK 1684770T3
- Authority
- DK
- Denmark
- Prior art keywords
- glucan
- beta
- cancer
- oligo
- monoclonal antibodies
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/698,034 US7070778B2 (en) | 2003-10-30 | 2003-10-30 | Therapeutical combination against cancer |
PCT/EP2004/013119 WO2005049044A1 (en) | 2003-10-30 | 2004-10-29 | Oligo-beta-(1, 3) -glucan and monoclonal antibodies against cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1684770T3 true DK1684770T3 (da) | 2009-11-09 |
Family
ID=34550517
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK04791108T DK1684770T3 (da) | 2003-10-30 | 2004-10-29 | Oligo-beta-(1, 3) -glucan og monoklonale antistoffer mod kræft |
Country Status (11)
Country | Link |
---|---|
US (1) | US7070778B2 (da) |
EP (1) | EP1684770B1 (da) |
AT (1) | ATE435020T1 (da) |
CY (1) | CY1109817T1 (da) |
DE (1) | DE602004021842D1 (da) |
DK (1) | DK1684770T3 (da) |
ES (1) | ES2328822T3 (da) |
PL (1) | PL1684770T3 (da) |
PT (1) | PT1684770E (da) |
SI (1) | SI1684770T1 (da) |
WO (1) | WO2005049044A1 (da) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7906492B2 (en) * | 2001-01-16 | 2011-03-15 | Sloan-Kettering Institute For Cancer Research | Therapy-enhancing glucan |
US7507724B2 (en) * | 2001-01-16 | 2009-03-24 | Sloan-Kettering Institute For Cancer Research | Therapy-enhancing glucan |
US8323644B2 (en) * | 2006-01-17 | 2012-12-04 | Sloan-Kettering Institute For Cancer Research | Therapy-enhancing glucan |
US20090053221A1 (en) * | 2006-01-17 | 2009-02-26 | Cheung Nai-Kong V | Immune response enhancing glucan |
US20090047288A1 (en) * | 2006-06-15 | 2009-02-19 | Jun Yan | Glucan compositions and methods of enhancing CR3 dependent neutrophil-mediated cytotoxicity |
CN100457766C (zh) * | 2006-09-26 | 2009-02-04 | 重庆邮电大学 | 非天然活性葡聚四糖烷基苷类化合物及其制备方法和应用 |
FR2910322B1 (fr) * | 2006-12-22 | 2009-10-30 | Mer Soc Par Actions Simplifiee | Utilisation d'oligo-b-(1,3)-glucanes modifies pour le traite traitement de maladies du systeme immunitaire, oligo-b-(1,3) glucane-(1,3)-mannose, oligo-b-(1,3)-glucane-(1,3)-mannitol et leurs derives, ... |
WO2009035617A1 (en) * | 2007-09-10 | 2009-03-19 | Barofold, Inc. | High-pressure refolding of monoclonal antibody aggregates |
US20110182888A1 (en) * | 2008-04-08 | 2011-07-28 | Peter Ordentlich | Administration of an Inhibitor of HDAC, an Inhibitor of HER-2, and a Selective Estrogen Receptor Modulator |
CN102308800A (zh) * | 2010-06-30 | 2012-01-11 | 中国科学院大连化学物理研究所 | 一种可德兰寡糖的应用 |
CN102405906B (zh) * | 2011-10-28 | 2013-10-23 | 海南正业中农高科股份有限公司 | 一种用于抗胡椒病毒病的壳寡糖组合物及其用途和方法 |
CN102415384B (zh) * | 2011-10-28 | 2013-12-25 | 海南正业中农高科股份有限公司 | 壳寡糖用于调节作物生长的用途 |
WO2014147199A1 (en) | 2013-03-20 | 2014-09-25 | Bioatlantis Ltd | A non-nematicidal composition and use thereof |
LT6145B (lt) | 2014-04-14 | 2015-04-27 | Uab "Biocentras" | TERAPINĖ ß-GLIUKANŲ KOMPOZICIJA, MODULIUOJANTI ŽMOGAUS IMUNINĘ SISTEMĄ IR INICIJUOJANTI VĖŽINIŲ LĄSTELIŲ ARDYMĄ |
EP3551685A1 (en) * | 2016-12-07 | 2019-10-16 | Innate Biotherapeutics, LLC | ß-1,6-GLUCAN TRASTUZUMAB ANTIBODY CONJUGATES |
EP3582810A4 (en) | 2016-12-07 | 2020-08-19 | Innate Biotherapeutics, LLC | Ss-1,6-GLUCAN THERAPEUTIC ANTIBODY CONJUGATES |
WO2023002252A1 (en) | 2021-07-21 | 2023-01-26 | Bioatlantis Limited | Composition comprising beta-glucans and alpha-fucans for improving gut health and animal performance and methods of making the same |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US45706A (en) * | 1865-01-03 | Improvement in apparatus for aerating dough | ||
CA2283452A1 (en) | 1997-03-04 | 1998-09-11 | Yveta Germano | Composition and method for treating cancer and immunological disorders resulting in chronic conditions |
FR2777281B1 (fr) | 1998-04-14 | 2000-06-30 | Goemar Lab Sa | Procede de synthese du d-laminaribiose |
FR2804684B1 (fr) | 2000-02-04 | 2002-06-28 | Goemar Lab Sa | Procede pour la preparation de derives fonctionnalises de beta-(1,3)-glucanes |
US6454697B1 (en) * | 2000-07-18 | 2002-09-24 | Dai-Yuan Wang | Cardiac support device and method |
US6660722B2 (en) | 2001-11-30 | 2003-12-09 | Laboratoires Goemar S.A. | Therapeutical treatments |
-
2003
- 2003-10-30 US US10/698,034 patent/US7070778B2/en not_active Expired - Fee Related
-
2004
- 2004-10-29 EP EP04791108A patent/EP1684770B1/en not_active Not-in-force
- 2004-10-29 PT PT04791108T patent/PT1684770E/pt unknown
- 2004-10-29 PL PL04791108T patent/PL1684770T3/pl unknown
- 2004-10-29 DE DE602004021842T patent/DE602004021842D1/de active Active
- 2004-10-29 WO PCT/EP2004/013119 patent/WO2005049044A1/en active Application Filing
- 2004-10-29 SI SI200431213T patent/SI1684770T1/sl unknown
- 2004-10-29 DK DK04791108T patent/DK1684770T3/da active
- 2004-10-29 AT AT04791108T patent/ATE435020T1/de active
- 2004-10-29 ES ES04791108T patent/ES2328822T3/es active Active
-
2009
- 2009-09-09 CY CY20091100936T patent/CY1109817T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
US7070778B2 (en) | 2006-07-04 |
EP1684770B1 (en) | 2009-07-01 |
SI1684770T1 (sl) | 2009-12-31 |
DE602004021842D1 (de) | 2009-08-13 |
PL1684770T3 (pl) | 2009-12-31 |
WO2005049044A1 (en) | 2005-06-02 |
PT1684770E (pt) | 2009-09-29 |
ES2328822T3 (es) | 2009-11-18 |
EP1684770A1 (en) | 2006-08-02 |
US20050095250A1 (en) | 2005-05-05 |
ATE435020T1 (de) | 2009-07-15 |
CY1109817T1 (el) | 2014-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1109817T1 (el) | Ολιγο-βητα-(1,3)-γλυκανη και μονοκλωνικα αντισωματα εναντιον καρκινου | |
CY1120070T1 (el) | Μεθοδοi θεραπευτικης αγωγης με τη χρηση συζευγματων αντισωματος εναντι-erbb-μεϋτανσινοειδους | |
CY1109525T1 (el) | ΑΝΘΡΩΠΟΠΟΙΗΜΕΝΑ ΑΝΤΙΣΩΜΑΤΑ ΑΝΤΙ-ErbB2 ΚΑΙ ΘΕΡΑΠΕΥΤΙΚΗ ΑΓΩΓΗ ΜΕ ΑΝΤΙΣΩΜΑΤΑ ΑΝΤΙ-ErbB2 | |
PL374865A1 (en) | Treatment of tnf alpha related disorders | |
MXPA05003621A (es) | Metodos de tratamiento de la enfermedad de alzheimer usando anticuerpos dirigidos contra el peptido beta amiloide y composiciones de los mismos. | |
DK1734995T3 (da) | Monoklonale antistoffer og hepatocyytvækstfaktor | |
LU91928I2 (fr) | Ipilimumab et ses dérivés pharmaceutiquement acceptables (YERVOY®) | |
MY154009A (en) | Anti-alpha v beta 6 antibodies | |
BR0011838A (pt) | Elementos misturadores estáticos empilhados | |
ATE470676T1 (de) | Anti-vegf-2 antikörper | |
MY145042A (en) | Humanized monoclonal antibodies to hepatocyte growth factor | |
DK0807125T3 (da) | Monoklonale antistoffer mod CD6 til behandling og diagnosticering af psoriasis | |
EA200601386A1 (ru) | ИММУНОГЛОБУЛИНЫ ПРОТИВ АНТИГЕНА EpCAM | |
ATE392219T1 (de) | Methoden und medizinische zusammensetzungen zur intravesikalen behandlung von blasenkrebs | |
DK1411962T3 (da) | Terapi for pancreacancer med monoklonalt stof | |
DK1545609T3 (da) | Antistoffer rettet mod oxideret apolipoprotein B | |
SE0202959D0 (sv) | Peptide-Base passive immunization therapy for treatment of atherosclerosis | |
AU2013204147B2 (en) | Treatment of TNFalpha related disorders | |
ATE490981T1 (de) | Criptospezifische antikörper |